Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 262.5 | 40 | ||||
RA2159 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 237.0 | 61 | |
RA2159 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 247.0 | 61 | |
RA2159 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 258.0 | 61 | |
RA2159 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 228.0 | 21 | |
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 283.0 | 59 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 272.0 | 31 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 232.0 | 51 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 243.0 | 33 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 215.0 | 19 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 218.0 | 24 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | GM-CSF | 232.0 | 46 | |
0 | GM-CSF | 206.0 | 58 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 244.0 | 47 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 220.5 | 62 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 192.5 | 72 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 214.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 229.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 199.0 | 51 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 246.0 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 213.0 | 57 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 269.0 | 65 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 266.0 | 56 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 181.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GM-CSF | 201.5 | 56 |